Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,974 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High levels of fibrotic tumor components are associated with recurrence and intratumoral immune status in advanced colorectal cancer patients.
Dorjkhorloo G, Shiraishi T, Erkhem-Ochir B, Sohda M, Okami H, Yamaguchi A, Shioi I, Komine C, Nakazawa N, Shibasaki Y, Okada T, Osone K, Sano A, Sakai M, Ogawa H, Katayama A, Oyama T, Yokobori T, Shirabe K, Saeki H. Dorjkhorloo G, et al. Among authors: oyama t. Sci Rep. 2024 Dec 28;14(1):30735. doi: 10.1038/s41598-024-80489-w. Sci Rep. 2024. PMID: 39730445 Free PMC article.
Low level of stromal lectin-like oxidized LDL receptor 1 and CD8+ cytotoxic T-lymphocytes indicate poor prognosis of colorectal cancer.
Katayama C, Yokobori T, Ozawa N, Suga K, Shiraishi T, Okada T, Osone K, Katoh R, Suto T, Motegi Y, Ogawa H, Sano A, Sakai M, Sohda M, Erkhem-Ochir B, Gombodorj N, Katayama A, Oyama T, Shirabe K, Kuwano H, Saeki H. Katayama C, et al. Among authors: oyama t. Cancer Rep (Hoboken). 2021 Aug;4(4):e1364. doi: 10.1002/cnr2.1364. Epub 2021 Mar 6. Cancer Rep (Hoboken). 2021. PMID: 33675293 Free PMC article.
Comparison of Risk Factors for Locally Advanced Lower Rectal Cancer Recurrence Evaluated by Magnetic Resonance Imaging and Pathological Factors Analysed by Longitudinal Slicing Method.
Shiraishi T, Ogawa H, Kumasaka S, Shimoda Y, Osone K, Okada T, Enokida Y, Sano A, Sakai M, Yokobori T, Tsushima Y, Oyama T, Sohda M, Shirabe K, Saeki H. Shiraishi T, et al. Among authors: oyama t. Anticancer Res. 2021 Jun;41(6):3169-3178. doi: 10.21873/anticanres.15103. Anticancer Res. 2021. PMID: 34083312
Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer.
Kurozumi S, Kaira K, Matsumoto H, Kurosumi M, Yokobori T, Kanai Y, Sekine C, Honda C, Katayama A, Furuya M, Shiino S, Makiguchi T, Mongan NP, Rakha EA, Oyama T, Fujii T, Shirabe K, Horiguchi J. Kurozumi S, et al. Among authors: oyama t. Sci Rep. 2022 Feb 17;12(1):2742. doi: 10.1038/s41598-022-06615-8. Sci Rep. 2022. PMID: 35177712 Free PMC article. Clinical Trial.
FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis.
Watanabe A, Harimoto N, Yokobori T, Araki K, Kubo N, Igarashi T, Tsukagoshi M, Ishii N, Yamanaka T, Handa T, Oyama T, Higuchi T, Shirabe K. Watanabe A, et al. Among authors: oyama t. Int J Clin Oncol. 2020 Feb;25(2):322-329. doi: 10.1007/s10147-019-01557-0. Epub 2019 Oct 14. Int J Clin Oncol. 2020. PMID: 31612350
1,974 results